NSETrading Window26 Jun 2026 · 26 Jun 2026, 07:10 pm
Trading Window
Aarti Drugs Limited · AARTIDRUGS
✦ AI Summary
Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from July 1, 2026, until the expiry of 48 hours after the declaration of Financial Results for the Quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
AARTIDRUGS_26062026191014_ADL.pdf
View document text
Ref: ADL/SE/2026-27/21
June 26, 2026
To, To,
Listing/ Compliance Department Listing/ Compliance Department
BSE Limited National Stock Exchange of India
Phiroze Jeejeebhoy Towers, Limited,
Dalal Street, “Exchange Plaza”, Plot No. C/1,
Mumbai – 400 001
G Block, Bandra - Kurla Complex, Bandra
(E), Mumbai – 400051
NSE SYMBOL: AARTIDRUGS
BSE CODE – 524348
Dear Sir/Madam,
Sub: Closure of ‘Trading Window’
Ref: SEBI (Prohibition of Insider Trading)
Regulations, 2015
This is to inform that the Trading Window of the Company will remain closed from July
1, 2026 until the expiry of 48 hours after the declaration of Financial Results for the
Quarter ended June 30, 2026.
Please take note of the above on your record.
Thanking You,
Yours faithfully,
FOR AARTI DRUGS LIMITED
RUSHIKESH DEOLE
COMPANY SECRETARY
ICSI M.No.: F12932